Search

Paresh C Gandhi

Examiner (ID: 305)

Most Active Art Unit
2663
Art Unit(s)
2663
Total Applications
1
Issued Applications
1
Pending Applications
0
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18201238 [patent_doc_number] => 11583611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-02-21 [patent_title] => Biocompatible phase invertible proteinaceous compositions and methods for making and using the same [patent_app_type] => utility [patent_app_number] => 16/878061 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6696 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878061 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878061
Biocompatible phase invertible proteinaceous compositions and methods for making and using the same May 18, 2020 Issued
Array ( [id] => 17799017 [patent_doc_number] => 11413283 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-16 [patent_title] => Topical formulations for delivery of hedgehog inhibitor compounds and use thereof [patent_app_type] => utility [patent_app_number] => 16/878301 [patent_app_country] => US [patent_app_date] => 2020-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 12 [patent_no_of_words] => 23679 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878301 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/878301
Topical formulations for delivery of hedgehog inhibitor compounds and use thereof May 18, 2020 Issued
Array ( [id] => 16282754 [patent_doc_number] => 20200276356 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875554 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875554 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875554
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 16282753 [patent_doc_number] => 20200276355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-03 [patent_title] => LARGE 3D POROUS SCAFFOLDS MADE OF ACTIVE HYDROXYAPATITE OBTAINED BY BIOMORPHIC TRANSFORMATION OF NATURAL STRUCTURES AND PROCESS FOR OBTAINING THEM [patent_app_type] => utility [patent_app_number] => 16/875543 [patent_app_country] => US [patent_app_date] => 2020-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12366 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16875543 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/875543
Large 3D porous scaffolds made of active hydroxyapatite obtained by biomorphic transformation of natural structures and process for obtaining them May 14, 2020 Issued
Array ( [id] => 17539791 [patent_doc_number] => 11304894 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-04-19 [patent_title] => Compositions, delivery devices, and methods thereof for feminine health [patent_app_type] => utility [patent_app_number] => 16/866454 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 11 [patent_no_of_words] => 8190 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866454 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/866454
Compositions, delivery devices, and methods thereof for feminine health May 3, 2020 Issued
Array ( [id] => 16663866 [patent_doc_number] => 10933088 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-02 [patent_title] => Method of administration and treatment [patent_app_type] => utility [patent_app_number] => 16/866466 [patent_app_country] => US [patent_app_date] => 2020-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 36355 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16866466 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/866466
Method of administration and treatment May 3, 2020 Issued
Array ( [id] => 16420681 [patent_doc_number] => 20200345879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-11-05 [patent_title] => GRIP ASSISTING AND ANTI CONTAGION DEVICES [patent_app_type] => utility [patent_app_number] => 16/862955 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16862955 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/862955
GRIP ASSISTING AND ANTI CONTAGION DEVICES Apr 29, 2020 Abandoned
Array ( [id] => 16569048 [patent_doc_number] => 20210008054 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => USE OF CDK9 INHIBITORS TO REDUCE CARTILAGE DEGRADATION [patent_app_type] => utility [patent_app_number] => 16/863892 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19479 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863892 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/863892
Use of CDK9 inhibitors to reduce cartilage degradation Apr 29, 2020 Issued
Array ( [id] => 17974331 [patent_doc_number] => 11491168 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-08 [patent_title] => Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof [patent_app_type] => utility [patent_app_number] => 16/858758 [patent_app_country] => US [patent_app_date] => 2020-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 67 [patent_no_of_words] => 18997 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858758 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/858758
Combination of Bcl-2/Bcl-xL inhibitors and chemotherapeutic agent and use thereof Apr 26, 2020 Issued
Array ( [id] => 18716427 [patent_doc_number] => 11793748 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2023-10-24 [patent_title] => Pharmaceutical compositions of aspirin for parenteral administration [patent_app_type] => utility [patent_app_number] => 16/840095 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4489 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16840095 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/840095
Pharmaceutical compositions of aspirin for parenteral administration Apr 2, 2020 Issued
Array ( [id] => 17695929 [patent_doc_number] => 11369631 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-06-28 [patent_title] => Oral gelling liquid formulations [patent_app_type] => utility [patent_app_number] => 16/839385 [patent_app_country] => US [patent_app_date] => 2020-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 8228 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16839385 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/839385
Oral gelling liquid formulations Apr 2, 2020 Issued
Array ( [id] => 17602855 [patent_doc_number] => 11331324 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-05-17 [patent_title] => Modified release suspension of eslicarbazepine [patent_app_type] => utility [patent_app_number] => 16/828858 [patent_app_country] => US [patent_app_date] => 2020-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7385 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16828858 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/828858
Modified release suspension of eslicarbazepine Mar 23, 2020 Issued
Array ( [id] => 17593690 [patent_doc_number] => 20220143263 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => THROMBIN-CARRYING HEMOSTATIC SHEET [patent_app_type] => utility [patent_app_number] => 17/440565 [patent_app_country] => US [patent_app_date] => 2020-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17728 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440565 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440565
THROMBIN-CARRYING HEMOSTATIC SHEET Mar 18, 2020 Pending
Array ( [id] => 16326680 [patent_doc_number] => 20200297645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => FIBROUS WATER-SOLUBLE UNIT DOSE ARTICLES COMPRISING WATER-SOLUBLE FIBROUS STRUCTURES [patent_app_type] => utility [patent_app_number] => 16/823375 [patent_app_country] => US [patent_app_date] => 2020-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11733 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16823375 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/823375
Fibrous water-soluble unit dose articles comprising water-soluble fibrous structures Mar 18, 2020 Issued
Array ( [id] => 17626203 [patent_doc_number] => 20220161218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-26 [patent_title] => METHOD FOR COATING INSOLUBLE SOLIDS [patent_app_type] => utility [patent_app_number] => 17/440061 [patent_app_country] => US [patent_app_date] => 2020-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6246 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17440061 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/440061
METHOD FOR COATING INSOLUBLE SOLIDS Mar 16, 2020 Pending
Array ( [id] => 16908001 [patent_doc_number] => 11040018 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-06-22 [patent_title] => Formulation for inhibiting formation of 5-HT2B agonists and methods of using same [patent_app_type] => utility [patent_app_number] => 16/811172 [patent_app_country] => US [patent_app_date] => 2020-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 8945 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16811172 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/811172
Formulation for inhibiting formation of 5-HT2B agonists and methods of using same Mar 5, 2020 Issued
Array ( [id] => 17155838 [patent_doc_number] => 20210316889 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => METHOD FOR FILLING CONTAINERS WITH A POWDER [patent_app_type] => utility [patent_app_number] => 17/279549 [patent_app_country] => US [patent_app_date] => 2020-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279549 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/279549
Method for filling containers with a powder Feb 25, 2020 Issued
Array ( [id] => 18525082 [patent_doc_number] => 11712059 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => Beaded tobacco material and related method of manufacture [patent_app_type] => utility [patent_app_number] => 16/798638 [patent_app_country] => US [patent_app_date] => 2020-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18457 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798638 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798638
Beaded tobacco material and related method of manufacture Feb 23, 2020 Issued
Array ( [id] => 16267172 [patent_doc_number] => 20200268659 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-27 [patent_title] => NALOXONE FORMULATIONS FOR SUBLINGUAL AND/OR BUCCAL ADMINISTRATION [patent_app_type] => utility [patent_app_number] => 16/797205 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797205 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/797205
Naloxone formulations for sublingual and/or buccal administration Feb 20, 2020 Issued
Array ( [id] => 16582735 [patent_doc_number] => 20210017137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => SALTS OF AN EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR [patent_app_type] => utility [patent_app_number] => 16/797776 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29629 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16797776 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/797776
Salts of an epidermal growth factor receptor kinase inhibitor Feb 20, 2020 Issued
Menu